All Stories

  1. Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention – Immune Tolerance trial

    Article • Diabetologia, September 2026, Springer Science + Business Media

    Dr Markus Lundgren

  2. Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol

    Article • Contemporary Clinical Trials Communications, April 2025, Elsevier

    Dr Markus Lundgren

  3. Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data

    Article • Diabetologia, February 2024, Springer Science + Business Media

    Dr Markus Lundgren

  4. Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes

    Article • Diabetes/Metabolism Research and Reviews, February 2024, Wiley

    Dr Markus Lundgren

  5. Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes

    Article • Diabetologia, January 2024, Springer Science + Business Media

    Dr Markus Lundgren

  6. Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study

    Article • BMJ Paediatrics Open, January 2024, BMJ

    Dr Markus Lundgren

  7. Effect of Oral Insulin on Early Combined Glucose and C‐Peptide Endpoints in Individuals at High‐Risk for Type 1 Diabetes

    Article • Pediatric Diabetes, January 2024, Wiley

    Dr Markus Lundgren

  8. Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance: the TEDDY study

    Article • European Journal of Medical Research, December 2023, Springer Science + Business Media

    Dr Markus Lundgren

  9. SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood

    Article • JAMA, September 2023, American Medical Association (AMA)

    Dr Markus Lundgren

  10. Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study

    Article • The Lancet Child & Adolescent Health, April 2023, Elsevier

    Dr Markus Lundgren

  11. Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity

    Article • Diabetes Care, March 2023, American Diabetes Association

    Dr Markus Lundgren

  12. Home Capillary Sampling and Screening for Type 1 Diabetes, Celiac Disease, and Autoimmune Thyroid Disease in a Swedish General Pediatric Population: The Triad Study

    Article • January 2023, Elsevier

    Dr Markus Lundgren

  13. Pancreatic Islet Β-Cell Function in Individuals with Multiple Islet Autoantibodies and Effects of Gluten-Free Diet

    Article • January 2023, Elsevier

    Dr Markus Lundgren

  14. The emotional well‐being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT ‐study

    Article • Pediatric Diabetes, November 2022, Wiley

    Dr Markus Lundgren

  15. Elevations in blood glucose before and after the appearance of islet autoantibodies in children

    Article • Journal of Clinical Investigation, October 2022, American Society for Clinical Investigation

    Dr Markus Lundgren

  16. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children

    Article • Diabetologia, October 2022, Springer Science + Business Media

    Dr Markus Lundgren

  17. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children

    Article • Pediatric Diabetes, September 2022, Wiley

    Dr Markus Lundgren

  18. Possible Relationship between the HLA-DRA1 Intron Haplotype of Three Single-Nucleotide Polymorphisms in Intron 1 of the HLA-DRA1 Gene and Autoantibodies in Children at Increased Genetic Risk for Autoimmune Type 1 Diabetes

    Article • ImmunoHorizons, August 2022, The American Association of Immunologists

    Dr Markus Lundgren

  19. Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study

    Article • The Lancet Diabetes & Endocrinology, August 2022, Elsevier

    Dr Markus Lundgren

  20. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease

    Article • Journal of Immunological Methods, July 2022, Elsevier

    Dr Markus Lundgren

  21. Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies

    Article • Journal of Immunology Research, May 2022, Hindawi Publishing Corporation

    Dr Markus Lundgren

  22. Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories

    Article • Nature Communications, March 2022, Springer Science + Business Media

    Dr Markus Lundgren

  23. Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2022, Endocrine Society

    Dr Markus Lundgren

  24. Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study

    Article • Diabetes Care, January 2022, American Diabetes Association

    Dr Markus Lundgren

  25. Is staff consistency important to parents’ satisfaction in a longitudinal study of children at risk for type 1 diabetes: the TEDDY study

    Article • BMC Endocrine Disorders, January 2022, Springer Science + Business Media

    Dr Markus Lundgren

  26. Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA

    Article • Clinical Diabetes and Endocrinology, December 2021, Springer Science + Business Media

    Dr Markus Lundgren

  27. Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children

    Article • Diabetes Care, November 2021, American Diabetes Association

    Dr Markus Lundgren

  28. Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol

    Article • BMJ Open, November 2021, BMJ

    Dr Markus Lundgren

  29. Is Staff Consistency Important to Parents’ Satisfaction in a Longitudinal Study of Children at Risk for Type 1 Diabetes: The TEDDY Study

    Article • October 2021, Research Square

    Dr Markus Lundgren

  30. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts

    Article • Diabetes Care, August 2021, American Diabetes Association

    Heba Ismail, Dr Markus Lundgren

  31. Islet autoimmunity and risk of type 1 diabetes from joint analyses of birth-cohort studies

    Article • Diabetes Care, June 2021, American Diabetes Association

    Vibha Anand, Dr Markus Lundgren

  32. 589-P: Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D)

    Article • Diabetes, June 2021, American Diabetes Association

    Dr Markus Lundgren

  33. Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count

    Article • Endocrine Reviews, April 2021, Endocrine Society

    Dr Markus Lundgren

  34. Children’s erythrocyte fatty acids are associated with the risk of islet autoimmunity

    Article • Scientific Reports, February 2021, Springer Science + Business Media

    Dr Markus Lundgren

  35. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child’s genetic risk

    Article • Diabetologia, January 2021, Springer Science + Business Media

    Dr Markus Lundgren

  36. Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA

    Article • Endocrinology Diabetes & Metabolism, November 2020, Wiley

    Dr Markus Lundgren

  37. Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2020, Endocrine Society

    Dr Markus Lundgren

  38. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort

    Article • Metabolomics, October 2020, Springer Science + Business Media

    Dr Markus Lundgren

  39. A combined risk score enhances prediction of type 1 diabetes among susceptible children

    Article • Nature Medicine, August 2020, Springer Science + Business Media

    Dr Markus Lundgren

  40. 248-OR: Visualizing Heterogeneous Islet Autoantibody Trajectories of Children Who Develop T1D from Multisite Birth Cohort Studies

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Markus Lundgren

  41. 342-OR: Optimal Ages for Screening for T1D Risk in Children

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Markus Lundgren

  42. 348-OR: Metabolic Phenotype of Autoantibody Positive (AbPos) Long-Term Nonprogressors (LTNPs) to Type 1 Diabetes (T1D)

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Markus Lundgren

  43. Parental anxiety after 5 years of participation in a longitudinal study of children at high risk of type 1 diabetes

    Article • Pediatric Diabetes, May 2020, Wiley

    Dr Markus Lundgren

  44. First European Case of Simultaneous Liver and Pancreas Transplantation as Treatment of Wolcott-Rallison Syndrome in a Small Child

    Article • Transplantation, March 2020, Wolters Kluwer Health

    Dr Markus Lundgren

  45. Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study

    Article • Diabetes, February 2020, American Diabetes Association

    Dr Markus Lundgren

  46. DPVis: Visual Analytics with Hidden Markov Models for Disease Progression Pathways

    Article • IEEE Transactions on Visualization and Computer Graphics, January 2020, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Markus Lundgren

  47. Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies

    Article • Journal of Translational Autoimmunity, January 2020, Elsevier

    Dr Markus Lundgren

  48. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

    Article • Diabetes Care, November 2019, American Diabetes Association

    Dr Markus Lundgren

  49. Metabolite-related dietary patterns and the development of islet autoimmunity

    Article • Scientific Reports, October 2019, Springer Science + Business Media

    Dr Markus Lundgren

  50. The relationship between breastfeeding and reported respiratory and gastrointestinal infection rates in young children

    Article • BMC Pediatrics, September 2019, Springer Science + Business Media

    Dr Markus Lundgren

  51. Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

    Article • BMJ Open, June 2019, BMJ

    Dr Markus Lundgren

  52. 211-OR: Analysis of Longitudinal Autoantibody Profiles and the Progression Rates to Type 1 Diabetes

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Markus Lundgren

  53. 1671-P: Comorbid Autoimmune Disease in Participants at Risk for Type 1 Diabetes

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Markus Lundgren

  54. 1690-P: Predicting Onset of Type 1 Diabetes Using a Novel Interaction Model

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Markus Lundgren

  55. 1345-P: Presymptomatic and Clinical T1D in The U.S., Sweden, and Finland: Joint Analysis of Four Birth Cohort Studies

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Markus Lundgren

  56. 163-OR: Sensitivity Analysis of Alternate Definitions of Multiple Islet Autoantibody Positivity

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Markus Lundgren

  57. Practical management in Wolcott‐Rallison syndrome with associated hypothyroidism, neutropenia, and recurrent liver failure: A case report

    Article • Clinical Case Reports, May 2019, Wiley

    Dr Markus Lundgren

  58. The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update

    Article • Current Diabetes Reports, October 2018, Springer Science + Business Media

    Dr Markus Lundgren

  59. Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study

    Article • Diabetologia, August 2018, Springer Science + Business Media

    Dr Markus Lundgren

  60. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study

    Article • Autoimmunity, July 2018, Taylor & Francis

    Berglind Jonsdottir, Dr Markus Lundgren, DR Helena Elding Larsson

  61. First trimester enterovirus IgM and beta cell autoantibodies in mothers to children affected by type 1 diabetes autoimmunity before 7 years of age

    Article • Journal of Reproductive Immunology, June 2018, Elsevier

    Dr Markus Lundgren

  62. Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study

    Article • Acta Diabetologica, May 2018, Springer Science + Business Media

    Dr Markus Lundgren

  63. Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy Study

    Article • Journal of Pediatric Gastroenterology and Nutrition, March 2018, Wolters Kluwer Health

    Dr Markus Lundgren

  64. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity

    Article • JAMA Pediatrics, December 2017, American Medical Association (AMA)

    Dr Markus Lundgren

  65. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial

    Article • Pediatric Diabetes, November 2017, Wiley

    Dr Markus Lundgren

  66. Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: results from the TEDDY study

    Article • Acta Diabetologica, August 2017, Springer Science + Business Media

    Dr Markus Lundgren

  67. Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity

    Article • BMC Pediatrics, May 2017, Springer Science + Business Media

    Dr Markus Lundgren

  68. Psychological Manifestations of Celiac Disease Autoimmunity in Young Children

    Article • PEDIATRICS, March 2017, American Academy of Pediatrics (AAP)

    Dr Markus Lundgren

  69. Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?

    Article • European Thyroid Journal, January 2017, Karger Publishers

    Dr Markus Lundgren

  70. Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type 1 diabetes in the population-based Diabetes Prediction in Skåne study

    Article • Diabetologia, October 2014, Springer Science + Business Media

    Dr Markus Lundgren

  71. Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up

    Article • Pediatric Diabetes, May 2014, Wiley

    Dr Markus Lundgren